Roche leads pre-JPM deal spree; Roger Perlmutter’s new pharma force; Inside Sage’s big triumph and failure; Late Friday IPO filings; All new drugs in 2023; and more

Welcome to the first issue of Endpoints Weekly in 2024! The year is starting strong, and there will be no shortage of topics for my colleagues to discuss with JP Morgan conference-goers. Say hi if you see them in San Francisco — and for those staying back, you can always…
Click here to view original post